Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TreatViD
2024-515978-27-00Phase 4Authorised
- Sponsor
- Azienda Ospedaliero-Universitaria Maggiore della Carità
- Start
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in pneumonia, coronavirus pneumonia and sepsis comparing High-dose cholecalciferol with Placebo (refined olive oil) (2 arms). Planned start Sep 2025; status: authorised.
02
Drugs
cholecalciferol
03
Conditions
pneumoniacoronavirus pneumoniasepsis
Beyond the preview
Go deeper on 2024-515978-27-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-515978-27-00.